1.Huflejt ME, Vuskovic M, Vasiliu D, Xu H, Obukhova P, Shilova N, Tuzikov A, Galanina O, Arun B, Lu K, Bovin N. Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges. Molecular Immunology 2009; 46, 3037-3049.2.Bovin NV. Natural antibodies to glycans. Biochemistry (Moscow) 2013, 78, 786-797.3.Vuskovic M, Xu H, Bovin N, Pass H, Huflejt M. Processing and analysis of serum antibody binding signals from Printed Glycan Arrays for diagnostic and prognostic applications. Int J Bioinformatics Res Appl 2011; 7: 402426.4.Smorodin JP, Kurtenkov OA, Miljukhina LM, Sergeyev BL, Hint EK, Bovin NV, Lipping AA, Chuzhmarov VJ. Thomsen-Friedenreich antigen-specific IgM antibodies: diagnostic significance for gastric and breast cancer. Exp Oncol 1997; 19: 338-342.5.Smorodin E, Sergeyev B, Klaamas K, Chuzmarov V, Kurtenkov O. The Relation of the Level of Serum Anti-TF, -Tn and -Alpha-Gal IgG to Survival in Gastrointestinal Cancer Patients. Int J Med Sci 2013; 10:1674-1682.6.Huflejt ME, Blixt O, Vuskovic M, Xu H, Shaw L, Reuben JM, Kuerer H, Cristofanilli M. Glycan array identifies specific signatures of anti-glycan autoantibodies in sera of breast cancer patients: diagnostic, prognostic and therapeutic opportunities. (2005) Br. Cancer Res Treat 2005; 94(Suppl. 1), S85.7.Jacob F, Goldstein DR, Bovin NV, Pochechueva T, Spengler M, Caduff R, Fink D, Vuskovic MI, Huflejt ME, Heinzelmann-Schwarz V. Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. Int. J. Cancer 2012; 130, 138-146.8.Butvilovskaya VI, Popletaeva SB, Chechetkin VR, Zubtsova ZI, Tsybulskaya MV, Samokhina LO, Vinnitskii LI, Ragimov AA, Pozharitskaya EI, Grigor Eva GA, Meshalkina NY, Golysheva SV, Shilova NV, Bovin NV, Zasedatelev AS, Rubina AY. Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips. Cancer Med 2016; 5(7), 1361-1372.9.Maverakis E, Kim K, Shimoda M, Gershwin ME, Patel F, Wilken R, Raychaudhuri S, Ruhaak LR, Lebrilla CB. Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review. J Autoimmun 2015; 57, 1-13.10.Willison HJ. Glycoconjugates and neuroimmunological diseases. Adv Neurobiol. 2014;9:543-66.11.D’Alessandro M, Mariani P, Lomanto D, Bachetoni A, Speranza V. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn’s disease and ulcerative colitis. Clin Immunol 2002; 103(1), 63-68.12.Ziganshina MM, Pavlovich SV, Bovin NV, Sukhikh GT. Hyaluronic Acid in Vascular and Immune Homeostasis during Normal Pregnancy and Preeclampsia. Acta Naturae 2016; 8(3), 59-71.13.Sukhikh GT, Ziganshina MM, Nizyaeva NV, Kulikova GV, Volkova JS, Yarotskaya EL, Kan NE, Shchyogolev AI, Tyutyunnik VL. Differences of glycocalyx composition in the structural elements of placenta in preeclampsia. Placenta 2016; 43, 69-76.14.Tupitsyn NN, Udalova YA, Galanina OE, Kadagidze ZG, Borovkova NB, Obukhova P, Shilova NV, Bovin NV. Tumor-associated glycan LewisC in breast cancer. Hematopoiesis immunology 2009; 2, 45-54.15.Bello-Gil D, Manez R. Exploiting natural anti-carbohydrate antibodies for therapeutic purposes. Biochemistry (Mosc) 2015; 80(7), 836-845.16.Whalen GF, Sullivan M, Piperdi B, Wasseff W, Galili U. Cancer immunotherapy by intratumoral injection of а-gal glycolipids. Anticancer Res 2012; 32(9), 3861-3868.